Essential Elements of Technology Transfer
Peter Alexander, Senior Consultant, CMC, co-authored an article about technology transfer categories, essential elements, and documentation.
If you’re developing a drug targeting a rare disease, you may need support with the complexity of obtaining an ODD. An RWE study could be the most appropriate approach to estimate the epidemiology of a disease and indeed demonstrate if it is rare.
This comprehensive guide to ISE/ISS content explains what the summaries must include for successful submission.
Peter Alexander, Senior Consultant, CMC, co-authored an article about technology transfer categories, essential elements, and documentation.
Our expert CMC team addresses the manufacturing challenges of ADCs in “Manufacturing Challenges of Therapeutic Antibody-Drug Conjugates.”
The NICE recommended routine funding for TRANSLARNA (ataluren) to treat Duchenne Muscular Dystrophy (DMD), based on RWE combined with feedback from patients, caregivers, and clinicians.
Our Transaction Advisory experts have analyzed the CDMO industry trends, M&A activities, and projected growth in this CHEManager article.
The client’s study aimed to assess the sensitivity and specificity of a novel diagnostic test for colorectal cancer in a large population representative of the diversity in the US.
Discover key market insights, deal activities and their implications, and factors driving the growth and evolution of the global CDMO market.
Alira Health is proud to announce it has been named by Forbes as one of the World's Best Management Consulting firms for 2023.
We are pleased to partner with Col·legi de Metges de Barcelona (CoMB), an institution that represents and serves the almost 39,000 physicians in Barcelona.
Alira Health announced today the publication of the Diabetes Management Devices Market Trends 2023, in collaboration with MassMEDIC, the Massachusetts Medical Device Industry Council.
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announced today the publication of the 2023 Biologics and Advanced Therapies Contract Manufacturing Report.
We are pleased to announce that Alira Health has joined HealthTech For Care, a French non-profit organization that is designed to support and promote access to healthcare for all.
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announced today the addition of the Learn Advocate Connect Neuroendocrine Tumor Society (LACNETS) to accompany its partnership with the Carcinoid Cancer Foundation (CCF) in supporting those living with NET.
Alira Health, in collaboration with MassMEDIC, released the Cardiology Medical Devices Market Trends 2023 with insights covering US & Europe.
To gain insight on the challenges and typical paths to failure, as well as a wide array of solutions for successful patient recruitment, we spoke with two Alira Health experts, Annabel de Maria, Chief Patient Officer, and Chris Rao, Senior Vice President of Clinical Operations.
Biotech experts Joris Pezzini and Chris Rao answer questions about the challenges of executing a successful clinical trial.
To learn about patient-focused listening sessions, their potential impact, and how manufacturers can prepare, we spoke with our experts.
We spoke with our inhouse experts to learn about the significance of the US Inflation Reduction Act for EU pharma and biotech companies.
Sneak peek at new report on the Diabetes Management Devices Market with insights including the trends, opportunities, and outlook for 2023.
Experts Joris Pezzini and Dan Pastore discuss the importance of fundraising, one of the three required jobs for successful biotech leaders.
Get in-depth market analysis, detailed examination of transactional activity, and insight into development of Biologics and ATs CDMO services.
Join a series of educational webinars on Value-Based Contracting led by payers and academic experts.
Engaging with patients, including their caregivers and advocates, is crucial during the planning and execution of clinical trials.
Engaging with patients, including their caregivers and advocates, is crucial during the planning and execution of clinical trials.
Review current trends shaping the US medical device outsourcing landscape, its performance and business outlook, and sustained M&A activity.
Gabriele Brambilla, CEO of Alira Health, has joined the MedTech World Podcast to discuss his experiences and journey in the Healthcare industry.
Watch this webinar to discover how the MedTech industry can successfully incorporate patient engagement activities at each stage of the medical device and diagnostic development product lifecycle.
Gabriele Brambilla, CEO and Co-Founder of Alira Health, joined The Next Iteration Podcast with hosts Damien Joseph and Fuad Ali to share his experiences of founding and developing Alira Health into a global leader in healthcare.